Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Medchemexpress LLC Elraglusib | 1034895-42-5 | 99.1% | 404.35 | 50 MG
Supplier: Medchemexpress LLC HY11391450MG
9-ING-41 (Elraglusib) is an ATP-competitive and selective inhibitor of glycogen synthase kinase-3β (GSK-3β), characterized by its maleimide-based structure and an IC50 of 0.71 μM. This compound plays a role in inducing cell cycle arrest, autophagy, and apoptosis in cancer cells, thereby exhibiting anticancer activity. It also holds potential for augmenting the antitumor effects of various chemotherapeutic agents.
- Leads to cell cycle arrest, autophagy, and apoptosis in cancer cells.
- Possesses anticancer activity.
- Potential for enhancing the antitumor effects of chemotherapeutic agents.
- Exhibits single-agent antitumor activity in a mouse model of MCL.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?